Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was CNY 164.654 million compared to CNY 110.275 million a year ago. Operating income was CNY 80.960 million compared to CNY 46.749 million a year ago. Net income was CNY 70.454 million compared to CNY 41.368 million a year ago. Basic earnings per share from continuing operations was CNY 0.1346 compared to CNY 0.079 a year ago.